Diagnosis dan Tata Laksana Kardiomiopati Peripartum

Tinjauan Pustaka

Penulis

  • Veronica Winda Soesanto Dr. Agoesdjam Ketapang Regional General Hospital, West Kalimantan, Indonesia
  • Billy Dr. Agoesdjam Ketapang Regional General Hospital, West Kalimantan, Indonesia https://orcid.org/0009-0005-1166-4616

DOI:

https://doi.org/10.55175/cdk.v52i4.1244

Kata Kunci:

Gagal jantung, kehamilan, Sesak napas

Abstrak

Kardiomiopati peripartum merupakan kelainan jantung dengan keluhan utama sesak napas, sering terlambat didiagnosis karena gejalanya mirip kondisi normal pada masa akhir kehamilan. Penyebab kardiomiopati peripartum adalah multifaktorial meliputi usia, ras, genetik, serta kondisi pre-eklampsia. Kardiomiopati peripartum membutuhkan keterampilan diagnosis dini dan tata laksana yang tepat untuk menurunkan risiko komplikasi jantung serta meningkatkan kualitas hidup ibu dan anak.

Unduhan

Data unduhan belum tersedia.

Biografi Penulis

Billy, Dr. Agoesdjam Ketapang Regional General Hospital, West Kalimantan, Indonesia

I am Billy Jonathan, a General Practicioner who’s highly motivated and eager to do public services. I graduated from Krida Wacana Christian University in Jakarta in late 2020. I’ve been practicing as GP for 3 years, and pursuing my carrer as future Obsgyn. I am now working at Government Hospital in West Kalimantan. I am a social magnet, so I can adapt easily in new environment. I have experience of leading one of the most influential Medical Organizations, so called Asian Medical Students Association - Ukrida (AMSA-Ukrida).

Referensi

Sliwa K, Bauersachs J, Arany Z, Spracklen TF, Hilfiker-Kleiner D. Peripartum cardiomyopathy: From genetics to management. Eur Heart J. 2021;42(32):3094–102. DOI: 10.1093/eurheartj/ehab458.

Mubarik A, Chippa V, Iqbal AM. Postpartum cardiomyopathy. StatPearls [Internet]. 2023 August [cited 2024 Sep 13]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK534770/.

Arany Z. Peripartum cardiomyopathy. Circulation 2016;133:1397-9. DOI: 10.1161/CIRCULATIONAHA.115.02049.

Koziol KJ, Aronow WS. Peripartum cardiomyopathy: Current understanding of pathophysiology, diagnostic workup, management, and outcomes. Curr Probl Cardiol. 2023;48(8):101716. DOI: 10.1016/j.cpcardiol.2023.101716.

Douglass EJ, Cooper LT, Morales-lara AC, Adedinsewo DA, Rozen TD, Blauwet LA, et al. A case-control study of peripartum cardiomyopathy using the Rochester epidemiology project. J Card Fail. 2021;27(2):132–42. DOI: 10.1016/j.cardfail.2020.12.021.

Karaye KM, Sa’idu Hadiza, Balarabe SA, Ishaq NA, Adamu UG, Mohammed IY, et al. Clinical features and outcomes of peripartum cardiomyopathy in Nigeria. J Am Coll Cardiol. 2020;76(20):2352–64. DOI: 10.1016/j.jacc.2020.09.540.

Yulriyanita MAB, Oktaliansah E. Penatalaksanaan kardiomiopati peripartum pada primigravida hamil 33–34 minggu gemeli di unit perawatan intensif. Maj Anest Crit Care. 2020;38(1):44–50.

Bala R, Mehta S, Roy VC, Kaur G, de Marvao A. Peripartum cardiomyopathy: A review. Rev Port Cardiol. 2023;42(11):917–24. DOI: 10.1016/j.repc.2023.01.029.

Peripartum cardiomyopathy. Panduan praktis klinis penatalaksanaan di bidang ilmu penyakit dalam. Interna Publishing; 2015 .p. 627–31.

Sliwa K, Bauersachs J, Arany Z, Spracklen TF, Hilfiker-Kleiner D. Peripartum cardiomyopathy: From genetics to management. Eur Heart J. 2021;42(32):3094–102. DOI: 10.1093/eurheartj/ehab458.

Davis MB, Arany Z, McNamara DM, Goland S, Elkayam U. Peripartum cardiomyopathy. J Am Coll Cardiol. 2020;75(2):207–21.

Hersunarti N, Siswanto BB, Erwinanto, Nauli SE, Lubis AC, Wiryawan N, et al. Kelompok kerja gagal jantung dan kardiometabolik Perhimpunan Dokter Spesialis Kardiovaskular Indonesia. Pedoman tatalaksana gagal jantung. PERKI: Indonesian Heart Association; 2020.

Anthony J, Sliwa K. Decompensated heart failure in pregnancy. Cardiac Failure Rev. 2016;2(1):20–6. DOI: 10.15420/cfr.2015:24:2.

Yunus N, Adiputro DL, Biworo A, Rudiansyah M, Illiandri O. Gambaran pemberian ace-inhibitor atau angiotensin receptor blocker pada pasien gagal jantung di RSUD Ulin Banjarmasin. Homeostasis. 2022;5(2):311–22. DOI: 10.20527/ht.v5i2.6276.

Felker GM, O’Connor CM, Braunwald E. Loop diuretics in acute decompensated heart failure. Circ Heart Fail. 2009;2(1):56–62. DOI: 10.1161/CIRCHEARTFAILURE.108.821785.

Contributors WE. Treating heart failure with ace-inhibitors. WebMD. [Internet]. 2024 May 24. Available from: https://www.webmd.com/heart-disease/heart-failure/heart-failure-ace-inhibitors.

Marti CN, Fonarow GC, Anker S, Yancy C, Vaduganathan M, Greene SJ, et al. Medication dosing for heart failure with reduced ejection fraction. Eur J Heart Fail. 2019;21(3):286–96. DOI: 10.1002/ejhf.1351.

Spironolactone helpful in CHF. Medscape [Internet]. [cited 2022 Aug 19]. Available from: https://www.medscape.com/editorial/series/119667.

Xiang Y, Shi W, Li Z, Yang Y, Wang SY, Xiang R, et al. Efficacy and safety of spironolactone in the heart failure with mid-range ejection fraction and heart failure with preserved ejection fraction: A meta-analysis of randomized clinical trials. Medicine (Baltimore). 2019;98(13):e14967. DOI: 10.1097/MD.0000000000014967.

Stolfo D, Uijl A, Benson L, Schrage B, Fudim M, Asselbergs FW, et al. Association between beta-blocker use and mortality/morbidity in older patients with heart failure with reduced ejection fraction. A propensity score-matched analysis from the Swedish Heart Failure Registry. Eur J Heart Fail. 2020;22(1):103–12. DOI: 10.1002/ejhf.1615.

Arfania M, Risna K, Musa KAE, Ardianti R, Dalimunthe YAS. Literatur review efektivitas beta bloker pada terapi pasien gagal jantung. Innov J Soc Sci Res. 2023;3(2):8076–88.

European Society of Gynecology (ESG); the Association for European Paediatric Cardiology (AEPC); the German Society for Gender Medicine (DGesGM), Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, et al. ESC guidelines on the management of cardiovascular diseases during pregnancy. Eur Heart J. 2011;32(24):3147–97. DOI: 10.1093/eurheartj/ehr218.

Sliwa K, Petrie MC, Hilfiker-Kleiner D, Mebazaa A, Jackson A, Johnson MR, et al. Long-term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy: Practical guidance paper from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy. Eur J Heart Fail. 2018;20(6):951–62. DOI: 10.1002/ejhf.1178.

Hosseinpour A, Hosseinpour H, Kheshti F, Abdollahifard S, Attar A. Prognostic value of various markers in recovery from peripartum cardiomyopathy: A systematic review and meta-analysis. ESC Heart Fail. 2022;9(5):3483–95. DOI: 10.1002/ehf2.14085.

Arany Z, Elkayam U. Peripartum cardiomyopathy. Circulation 2016;133(14):1397–409. DOI: 10.1161/CIRCULATIONAHA.115.0204. Modified World Health Organization (WHO) classification of maternal cardiovascular risk - application [Internet]. [cited 2024 Jun 7]. Available from: https://www.researchgate.net/figure/Modified-WHO-classification-of-maternal-cardiovascular-risk-application_tbl3_51601444.

Unduhan

Diterbitkan

2025-04-07

Cara Mengutip

Soesanto, V. W., & Jonathan, B. (2025). Diagnosis dan Tata Laksana Kardiomiopati Peripartum: Tinjauan Pustaka. Cermin Dunia Kedokteran, 52(4), 236–240. https://doi.org/10.55175/cdk.v52i4.1244

Terbitan

Vol 52 No 4 (2025): Kedokteran Umum

Bagian

Articles

Lisensi

Hak Cipta (c) 2025 Veronica Winda Soesanto, Billy Jonathan

Creative Commons License

Artikel ini berlisensi Creative Commons Attribution-NonCommercial 4.0 International License.